Levi & Korsinsky Notifies Shareholders of Kyverna Therapeutics, Inc. (KYTX) of a Class Action Lawsuit and an Upcoming Deadline

Core Viewpoint - Kyverna Therapeutics, Inc. (KYTX) is facing a class action lawsuit, which has been notified to its shareholders by Levi & Korsinsky, indicating potential legal challenges for the company [1] Group 1 - The class action lawsuit is related to allegations against Kyverna Therapeutics, which may impact the company's reputation and financial standing [1] - Shareholders are urged to be aware of an upcoming deadline concerning the lawsuit, emphasizing the importance of timely action [1] - The notification serves as a reminder for investors to stay informed about legal proceedings that could affect their investments in Kyverna Therapeutics [1]